Subscribe


PD breaking news – GSK posts $42m profit

GSK has reported $42m in total profit before tax for 2013.

GlaxoSmithKline (GSK) has reported total profit before tax of $42m for 2013 on sales of $1,414m.

Reporting to the Australian Securities and Investment Commission, the company said its Australian group sales had decreased on the year prior but that profit before tax was up “marginally”.

Exports were down 1% to $515m for the period, GSK said.

Business performance had been solid despite continuing challenges facing the pharmaceutical industry, GSK pharmaceuticals Australia general manager Geoff McDonald said.

“A decline in sales for the commercial pharmaceutical business has occurred as the full year impact of the divestment of our classic brands to Aspen Global Incorporated (Aspen) in late 2012 was realised.”

The Consumer Healthcare division saw a drop in commercial sales, of 4%, and manufacturing sales, of 20%, GSK said.

Pharmaceutical manufacturing sales were up about 17%, GSK said, and its Opiates business “continued to perform strongly, seeing growth year on year for the last three years.”

For more, see tomorrow’s Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 03 Jun 14

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

21 Aug

Weekly Comment 21 Aug 17: Don’t burn your bridges – Part 1 - This week's contributor is Amy Filicietti, Recruitment ...


21 Aug

Dispensary Corner 21 Aug 17 - THERE'S been a major fake tan fail ...


21 Aug

Healthscope sells medical centres - HEALTHSCOPE Limited on Fri confirmed the $55 ...


21 Aug

Generic orlistat - ARROW Pharma has announced the launch of ...


21 Aug

CW stocks SASMAR - SASMAR has announced that its Conceive Plus ...


21 Aug

Connect with CPD - NEXT week's Pharmacy Connect conference at the ...


21 Aug

JPPR vulnerable focus - THE latest issue of the flagship publication ...


21 Aug

Fake meds webinar - THE International Pharmaceutical Federation (FIP) has announced ...


21 Aug

30% pharmacist pay rise push - PROFESSIONAL Pharmacists Australia has launched a campaign ...


21 Aug

Practice guidelines revised - THE Pharmaceutical Society of Australia (PSA) has ...


18 Aug

Events Calendar 18 Aug 17 - 1-3 Sep: Pharmacy Connect; Hilton Hotel Sydney; ...


18 Aug

Dispensary Corner 18 Aug 17 - THE "afterburner effect" is probably a significant ...


18 Aug

Soliris patent extends - ALEXION Pharmaceuticals has announced that the United ...


18 Aug

New US telepharmacy - RETAIL giant Kmart has opened its first ...


18 Aug

Aus/NZ paracetamol poisoning guidelines - UPDATED guidelines around management of paracetamol poisoning ...


18 Aug

UK OTC psoriasis - BRITAIN'S Medicines and Healthcare products Regulatory Agency ...


18 Aug

TGA balances Lateline - THE Therapeutic Goods Administration's (TGA's) Special Access ...


18 Aug

Medicine misuse - NPS MedicineWise's 7th annual campaign has been ...


18 Aug

Course fever runs hot - GUILD Learning and Development has partnered with ...


18 Aug

FDA Zika samples - THE US Food and Drug Administration (FDA) ...



Show Pharmacy Daily items by month: